期刊文献+

视网膜淋巴瘤治疗中视网膜动脉阻塞1例并文献复习

Retinal artery occlusion during treatment of primary vitreoretinal lymphoma:a case report and literature review
原文传递
导出
摘要 目的 报道1例玻璃体视网膜淋巴瘤治疗过程中出现视网膜动脉阻塞病例的临床特征及治疗要点,分析其形成的相关原因。方法 回顾该病例的诊断和治疗过程,结合病例资料及相关文献进行分析讨论。结果 入院后根据病史、症状及体征,行眼内液细胞因子检测及基因重排,诊断为“玻璃体视网膜淋巴瘤”。给予多次玻璃体腔注射甲氨蝶呤治疗,定期复查,拟行再次玻璃体腔注射前,出现视网膜动脉阻塞。结论 玻璃体视网膜淋巴瘤的诊断具有挑战性,因其临床症状可以模仿其他眼部疾病,在治疗过程中,需要关注眼部及全身系统情况,提高患者生活质量及生存时间。 Objective This study reports the clinical features and treatment of a case of retinal artery occlusion during vitreoretinal lymphoma treatment.We also analyze and describe the relevant reasons for retinal artery occlusion formation.Methods The diagnosis and treatment of the case were reviewed.The case data and related literature were analyzed and discussed.Results After admission,according to the medical history,symptoms,and signs,cytokines in intraocular fluids and gene rearrangement were detected and a diagnosis of"vitreoretinal lymphoma"was established.Methotrexate intravitreal injection and regular follow-up were performed.However,retinal artery occlusion occurred before another planned intravitreal injection.Conclusion Vitreoretinal lymphoma diagnosis is challenging because its clinical symptoms could mimic other eye diseases.In the treatment course,attention should be paid to the eye and systemic system to improve patients'quality of life and survival time.
作者 赵慧 黄超 崔文轩 司明威 杨梦瑶 王红 周芳 ZHAO Hui;HUANG Chao;CUI Wenxuan;SI Mingwei;YANG Mengyao;WANG Hong;ZHOU Fang(Department of Ophthalmology,Qilu Hospital of Shandong University,Jinan 250012,Shandong,China)
出处 《山东大学耳鼻喉眼学报》 CAS 2023年第5期123-127,共5页 Journal of Otolaryngology and Ophthalmology of Shandong University
关键词 玻璃体视网膜淋巴瘤 甲氨蝶呤 视网膜动脉阻塞 治疗 Retinal artery occlusion Primary vitreoretinal lymphoma Methotrexate Treatment
  • 相关文献

参考文献4

二级参考文献34

  • 1李京京,顼晋昆,李莉.EB病毒阳性的扁桃体溃疡临床特征分析[J].山东大学耳鼻喉眼学报,2020,34(1):58-62. 被引量:1
  • 2钟艳平,杨华,王连有,刘学娟.儿童扁桃体原发性恶性B细胞淋巴瘤临床病理观察[J].诊断病理学杂志,2005,12(5):350-352. 被引量:3
  • 3Chan CC, Sen HN. Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma [J].Discov Med, 2013, 15(81): 93-100.
  • 4Touitou V, Lehoang P, 13odaghi B. Primary CNS lymphoma [J~. Curr Opin Ophthalmol, 2015, 26(6): 526-533. DOh10. 1097/ICU. 0000000000000:113.
  • 5Chan CC, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal lymphoma: a report from an international primary central nervous system lymphoma collaborative group symposium [J]. Oneologist, 2011, 16(11): 1589-1599. DOh 10. 1634/ theoncologist. 2011-0210.
  • 6Grimm SA, Pulido JS, Jahnke K, et al. Primary intraocular lyraphoma: an ~.nternatio~a[ primary central nervous system lymphoma collaborative group report [J]. Ann Oncol, 2007, 18 (11) ~ 1851-1855.
  • 7Fishbume BC, Wilson DJ, Rosenbaum JT, et al. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma [J]. ArchOphthalmol, 1937, 115(9): 1152-1156.
  • 8Frenkel S, Hendler K, Siegal T, et al. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience [J]. Br J Ophthalmol, 2008, 92 (3), 383-388.
  • 9Riemens A, Bromberg J, Touitou V, et al. Treatment strategies in primary vitreoretinal lymphoma~ a 17-center European collaborative study [J]. JAMA Ophthalmol, 2015, 13a (2).. 191-197.
  • 10Smith JR, Rosenbaum JT, Wilson DJ, et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement rJ]. Ophthalmology, 2002, 109(9): 1709-1716.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部